Abstract
The use of cyclosporin A (CyA) with a protocol designed to avoid the effects of nephrotoxicity resulted in a one-year survival of 86% in recipients of renal allografts from unmatched cadaveric donors. The drug also controlled rejection of liver and pancreatic allografts. It was possible to change patients initially treated with CyA to azathioprine and corticosteroids and vice versa, thus enlarging the potential value of CyA in organ allografting. Of 34 recipients of renal allografts, 29 were currently receiving only CyA as immunosuppressive treatment. Twelve patients never required any adjuvant steroid treatment. These results suggest that CyA is an effective immunosuppressant, and if used with care side effects need not be severe.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Calne R. Y., Rolles K., White D. J., Thiru S., Evans D. B., McMaster P., Dunn D. C., Craddock G. N., Henderson R. G., Aziz S. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979 Nov 17;2(8151):1033–1036. doi: 10.1016/s0140-6736(79)92440-1. [DOI] [PubMed] [Google Scholar]
- Calne R. Y., White D. J., Thiru S., Evans D. B., McMaster P., Dunn D. C., Craddock G. N., Pentlow B. D., Rolles K. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet. 1978 Dec 23;2(8104-5):1323–1327. doi: 10.1016/s0140-6736(78)91970-0. [DOI] [PubMed] [Google Scholar]
- Dubernard J. M., Traeger J., Neyra P., Touraine J. L., Tranchant D., Blanc-Brunat N. A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man. Surgery. 1978 Nov;84(5):633–639. [PubMed] [Google Scholar]
- Land W., Weitz H. Prolamine solution to block pancreatic duct. Lancet. 1979 Nov 24;2(8152):1131–1131. [PubMed] [Google Scholar]
- McMaster P., Procyshyn A., Calne R. Y., Valdes R., Rolles K., Smith D. J. Prolongation of canine pancreas allograft survival with cyclosporin A: preliminary report. Br Med J. 1980 Feb 16;280(6212):444–445. doi: 10.1136/bmj.280.6212.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Powles R. L., Clink H. M., Spence D., Morgenstern G., Watson J. G., Selby P. J., Woods M., Barrett A., Jameson B., Sloane J. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet. 1980 Feb 16;1(8164):327–329. doi: 10.1016/s0140-6736(80)90881-8. [DOI] [PubMed] [Google Scholar]
- Rolles K., Calne R. Y. Two cases of benign lumps after treatment with cyclosporin A. Lancet. 1980 Oct 11;2(8198):795–795. doi: 10.1016/s0140-6736(80)90401-8. [DOI] [PubMed] [Google Scholar]
- Starzl T. E., Weil R., 3rd, Iwatsuki S., Klintmalm G., Schröter G. P., Koep L. J., Iwaki Y., Terasaki P. I., Porter K. A. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet. 1980 Jul;151(1):17–26. [PMC free article] [PubMed] [Google Scholar]